 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| DrugBank |
|
| ChemSpider |
|
| UNII | |
| KEGG |
|
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| ECHA InfoCard | 100.012.267 |
| Chemical and physical data | |
| Formula | C14H19N3O |
| Molar mass | 245.326 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
 N Y (what is this?) (verify) | |
Oxolamine is acough suppressant[1] that is available as ageneric drug in many jurisdictions.[2]
Oxolamine also hasanti-inflammatory activity, which causes a reduction in irritation of the nerve receptors of therespiratory tract.[3]
It is mainly used for the treatment ofpharyngitis,tracheitis,bronchitis, bronchiectasis andpertussis.[3]
Oxolamine is not approved in the USA, it may be marketed elsewhere internationally as a cough suppressant. It is listed as aprescription drug in New Zealand legislation. Oxolamine is also approved in Taiwan for the treatment ofrespiratory tract inflammation.[4]
 | Thisdrug article relating to therespiratory system is astub. You can help Wikipedia byexpanding it. |